See more : Edison Lithium Corp. (EDDYF) Income Statement Analysis – Financial Results
Complete financial analysis of Flotek Industries, Inc. (FTK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Flotek Industries, Inc., a leading company in the Oil & Gas Equipment & Services industry within the Energy sector.
You may be interested
- APIS INDIA LTD. (APIS.BO) Income Statement Analysis – Financial Results
- Alkhabeer REIT Fund (4348.SR) Income Statement Analysis – Financial Results
- Augmentum Fintech PLC (AUGM.L) Income Statement Analysis – Financial Results
- Sailfish Royalty Corp. (SROYF) Income Statement Analysis – Financial Results
- DT Cloud Star Acquisition Corporation (DTSQU) Income Statement Analysis – Financial Results
Flotek Industries, Inc. (FTK)
About Flotek Industries, Inc.
Flotek Industries, Inc. operates as a technology-driven chemistry and data company that serves customers across industrial, commercial, and consumer markets in the United States, the United Arab Emirates, and internationally. It operates in two segments, Chemistry Technologies (CT) and Data Analytics (DA). The CT segment designs, develops, manufactures, packages, distributes, delivers, and markets green specialty chemicals that enhance the profitability of hydrocarbon producers and cleans surfaces in commercial and personal settings to help reduce the spread of bacteria, viruses, and germs. This segment primarily serves integrated oil and gas, oilfield services, independent oil and gas, national and state-owned oil, geothermal energy, solar energy, and alternative energy companies. The DA segment designs, develops, produces, sells, and supports equipment and services that create and provide valuable information on the composition and properties of energy customers' hydrocarbon fluids. This segment's data platforms combine the energy industry's field-deployable, inline optical analyzer with proprietary cloud visualization and analytics. It sells its products directly through a mix of in-house sales professionals, as well as contractual agency agreements. The company was incorporated in 1985 and is headquartered in Houston, Texas.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 188.06M | 136.09M | 43.27M | 53.14M | 119.35M | 177.77M | 317.10M | 262.83M | 334.36M | 449.16M | 371.07M | 312.83M | 258.79M | 146.98M | 112.55M | 226.06M | 158.01M | 100.64M | 52.87M | 21.88M | 14.84M | 13.26M | 12.56M | 1.56M | 1.79M | 3.18M |
| Cost of Revenue | 163.80M | 142.79M | 40.01M | 3.41M | 8.47M | 9.22M | 227.29M | 172.15M | 219.25M | 266.20M | 223.54M | 181.21M | 152.97M | 94.01M | 83.17M | 135.31M | 90.30M | 59.46M | 30.95M | 12.53M | 9.26M | 8.71M | 9.08M | 1.16M | 1.15M | 2.44M |
| Gross Profit | 24.26M | -6.70M | 3.26M | 49.73M | 110.89M | 168.56M | 89.81M | 90.68M | 115.11M | 182.96M | 147.53M | 131.62M | 105.82M | 52.97M | 29.38M | 90.76M | 67.71M | 41.18M | 21.92M | 9.35M | 5.58M | 4.55M | 3.48M | 396.87K | 644.37K | 742.95K |
| Gross Profit Ratio | 12.90% | -4.92% | 7.53% | 93.58% | 92.91% | 94.82% | 28.32% | 34.50% | 34.43% | 40.73% | 39.76% | 42.07% | 40.89% | 36.04% | 26.11% | 40.15% | 42.85% | 40.92% | 41.47% | 42.74% | 37.59% | 34.31% | 27.73% | 25.41% | 35.92% | 23.35% |
| Research & Development | 2.49M | 4.44M | 5.54M | 7.21M | 8.86M | 10.36M | 13.65M | 9.32M | 7.46M | 4.98M | 3.75M | 3.18M | 2.34M | 1.44M | 2.12M | 1.93M | 849.00K | 656.00K | 555.26K | 300.07K | 46.65K | 139.37K | 34.94K | 21.08K | 0.00 | 4.16K |
| General & Administrative | 0.00 | 0.00 | 0.00 | 16.31M | 27.98M | 31.47M | 78.73M | 80.15M | 95.48M | 87.15M | 78.20M | 66.42M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 712.98K | 735.07K | 1.39M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 37.24M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 877.78K | 1.02M | 1.53M |
| SG&A | 27.87M | 27.12M | 20.17M | 16.31M | 27.98M | 31.47M | 78.73M | 80.15M | 95.48M | 87.15M | 78.20M | 66.42M | 50.61M | 41.86M | 36.94M | 46.31M | 30.64M | 18.92M | 9.49M | 5.35M | 4.79M | 7.48M | 3.77M | 1.59M | 1.75M | 2.92M |
| Other Expenses | -29.32M | 734.00K | 1.01M | 88.27M | 149.23M | -5.04M | 812.00K | -303.00K | -181.00K | -394.00K | 316.00K | -452.00K | 3.98M | 6.65M | 4.93M | 5.57M | 6.54M | 2.75M | 1.77M | 689.90K | 713.53K | 1.30M | 744.31K | 122.81K | 62.25K | 93.10K |
| Operating Expenses | 30.36M | 32.30M | 26.71M | 111.79M | 186.06M | 201.63M | 92.37M | 98.00M | 113.94M | 101.86M | 89.22M | 74.01M | 56.93M | 49.95M | 43.99M | 53.81M | 38.03M | 22.33M | 11.81M | 6.34M | 5.55M | 8.92M | 4.55M | 1.71M | 1.81M | 3.02M |
| Cost & Expenses | 164.84M | 175.09M | 66.73M | 115.20M | 194.53M | 210.85M | 319.66M | 270.15M | 333.19M | 368.06M | 312.76M | 255.22M | 209.90M | 143.96M | 127.15M | 189.12M | 128.32M | 81.79M | 42.76M | 18.87M | 14.81M | 17.63M | 13.63M | 2.88M | 2.96M | 5.46M |
| Interest Income | 0.00 | 7.05M | 78.00K | 60.00K | 2.02M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.22K | 43.82K | 0.00 | 0.00 | 0.00 |
| Interest Expense | 2.86M | 7.05M | 78.00K | 60.00K | 2.02M | 2.87M | 2.17M | 1.98M | 1.76M | 1.61M | 2.09M | 8.10M | 15.96M | 20.22M | 15.43M | 10.23M | 3.50M | 1.01M | 827.09K | 691.57K | 618.44K | 639.92K | 415.43K | 173.78K | 173.78K | 30.45K |
| Depreciation & Amortization | 8.78M | 4.33M | 1.29M | 3.77M | 9.21M | 9.22M | 9.77M | 10.43M | 18.02M | 9.74M | 15.11M | 11.58M | 10.11M | 13.77M | 14.19M | 13.87M | 6.54M | 2.75M | 1.77M | 689.90K | 713.53K | 704.73K | 744.31K | 122.81K | 62.25K | 93.10K |
| EBITDA | 36.50M | -34.54M | -29.63M | -138.80M | -64.59M | -68.58M | 544.00K | 15.55M | 21.00M | 66.31M | 74.81M | 65.14M | 65.34M | -15.03M | -19.07M | -18.00M | 36.22M | 21.52M | 11.80M | 3.75M | 744.94K | -2.09M | -319.43K | 132.39K | -1.19M | -1.11M |
| EBITDA Ratio | 19.41% | -27.95% | -51.68% | -109.42% | -54.46% | -16.26% | 3.28% | 1.07% | 5.69% | 20.14% | 19.87% | 21.97% | 22.80% | 11.42% | -0.37% | 82.41% | 22.92% | 21.38% | 22.31% | 16.71% | 73.83% | -27.65% | -2.76% | -76.72% | -66.64% | -67.74% |
| Operating Income | 23.22M | -35.42M | -23.46M | -62.06M | -75.18M | -69.81M | -2.86M | -7.30M | -19.17M | 80.89M | 58.73M | 58.62M | 48.89M | -6.27M | -33.10M | -30.75M | 29.69M | 18.85M | 10.11M | 3.01M | -5.09M | -4.37M | -1.06M | -1.32M | -1.17M | -2.28M |
| Operating Income Ratio | 12.35% | -26.03% | -54.22% | -116.79% | -62.99% | -39.27% | -0.90% | -2.78% | -5.73% | 18.01% | 15.83% | 18.74% | 18.89% | -4.26% | -29.41% | -13.60% | 18.79% | 18.73% | 19.13% | 13.77% | -34.28% | -32.97% | -8.47% | -84.31% | -65.12% | -71.62% |
| Total Other Income/Expenses | 1.64M | -6.91M | 890.00K | 1.02M | -636.00K | -10.85M | -1.07M | 10.45M | -1.64M | 20.27M | -1.78M | -13.16M | -9.62M | -42.74M | -15.59M | -13.91M | -2.55M | -920.00K | -741.07K | -645.09K | -591.45K | -566.00 | 27.42K | 4.29K | 238.11K | -1.14M |
| Income Before Tax | 24.86M | -42.33M | -30.57M | -142.63M | -76.94M | -80.66M | -4.21M | 3.14M | -21.12M | 78.88M | 56.95M | 45.46M | 39.27M | -49.01M | -48.69M | -41.08M | 27.14M | 17.93M | 9.37M | 2.37M | 31.41K | -4.37M | -1.04M | -1.31M | -1.08M | -2.31M |
| Income Before Tax Ratio | 13.22% | -31.10% | -70.64% | -268.40% | -64.46% | -45.37% | -1.33% | 1.20% | -6.32% | 17.56% | 15.35% | 14.53% | 15.17% | -33.34% | -43.26% | -18.17% | 17.18% | 17.82% | 17.73% | 10.82% | 0.21% | -32.97% | -8.25% | -84.03% | -60.13% | -72.58% |
| Income Tax Expense | 149.00K | -22.00K | -40.00K | -6.18M | -201.00K | -7.22M | 8.84M | 1.24M | -7.65M | 25.28M | 20.77M | -4.33M | 7.86M | -5.55M | 2.02M | -9.14M | 10.41M | 6.58M | 1.65M | 213.10K | 17.01M | 451.66K | -98.65K | -8.59K | -44.24K | 184.47K |
| Net Income | 24.71M | -42.31M | -30.53M | -136.45M | -76.74M | -70.34M | -27.40M | -49.13M | -13.46M | 53.60M | 36.18M | 49.79M | 31.41M | -43.47M | -50.71M | -31.94M | 16.73M | 11.35M | 7.72M | 2.15M | -7.38M | -5.46M | -1.41M | -1.49M | -1.21M | -2.43M |
| Net Income Ratio | 13.14% | -31.09% | -70.55% | -256.77% | -64.29% | -39.57% | -8.64% | -18.69% | -4.03% | 11.93% | 9.75% | 15.92% | 12.14% | -29.57% | -45.05% | -14.13% | 10.59% | 11.28% | 14.60% | 9.84% | -49.74% | -41.20% | -11.21% | -95.16% | -67.65% | -76.46% |
| EPS | -0.12 | -3.41 | -2.50 | -11.98 | -7.84 | -7.28 | -2.85 | -5.30 | -1.47 | 4.36 | 4.23 | 6.20 | 0.60 | -1.69 | -2.59 | -1.67 | 0.91 | 0.66 | 0.53 | 0.16 | -0.62 | -0.55 | -0.22 | -0.01 | -1.50 | -4.29 |
| EPS Diluted | -0.10 | -3.41 | -2.50 | -11.98 | -7.84 | -7.28 | -2.85 | -5.26 | -1.47 | 4.26 | 4.02 | 5.80 | 0.56 | -1.69 | -2.59 | -1.67 | 0.88 | 0.61 | 0.47 | 0.16 | -0.62 | -0.55 | -0.22 | -0.01 | -1.50 | -4.29 |
| Weighted Avg Shares Out | 24.83M | 12.40M | 12.23M | 11.39M | 9.79M | 9.67M | 9.60M | 9.26M | 9.17M | 9.25M | 8.97M | 8.59M | 44.23M | 25.73M | 19.60M | 19.16M | 18.34M | 17.29M | 14.61M | 13.32M | 11.95M | 9.94M | 6.35M | 104.06M | 808.91K | 567.26K |
| Weighted Avg Shares Out (Dil) | 28.38M | 12.40M | 12.23M | 11.39M | 9.79M | 9.67M | 9.60M | 9.35M | 9.18M | 9.30M | 9.00M | 8.93M | 47.64M | 25.73M | 19.60M | 19.16M | 18.96M | 18.59M | 16.51M | 14.03M | 11.95M | 9.94M | 6.35M | 104.06M | 808.91K | 567.26K |
Earnings Outlook for Flotek Industries
Flotek Industries (NYSE:FTK) announces its next round of earnings this Tuesday, March 16. Here is Benzinga's look at Flotek Industries's Q4 earnings report.
Flotek Industries Announces New Date For Fourth Quarter And Full-Year 2020 Results
HOUSTON, March 10, 2021 /PRNewswire/ -- Flotek Industries, Inc. ("Flotek" or the "Company") (NYSE: FTK) today announced it is rescheduling its fourth quarter 2020 earnings results previously scheduled for Wednesday, March 10, 2021, and corresponding conference call scheduled for Thursday, March...
Flotek Industries Announces Earnings Schedule For Q4 And Full-Year 2020 Results
HOUSTON, Feb. 18, 2021 /PRNewswire/ -- Flotek Industries, Inc. ("Flotek" or the "Company") (NYSE: FTK) today announced the Company's schedule for releasing its fourth quarter 2020 results for the three months ended December 31, 2020. Earnings Schedule Announced for Q4...
Flotek Industries, Inc. (FTK) CEO John Gibson on Q3 2020 Results - Earnings Call Transcript
Flotek Industries, Inc. (FTK) CEO John Gibson on Q3 2020 Results - Earnings Call Transcript
Flotek Announces Third Quarter 2020 Earnings Results
HOUSTON, Nov. 16, 2020 /PRNewswire/ -- Flotek Industries, Inc. ("Flotek" or the "Company") (NYSE: FTK) today announced results for the third quarter ended September 30, 2020. "It has been a challenging period as we continue to navigate through this global...
Is Flotek Industries (FTK) a Smart Long-term Buy?
Artko Capital recently released its Q3 2020 Investor Letter, a copy of which you can download here. The fund posted a return of 22.0% for the quarter, outperforming its benchmark, the S&P 500 Index which returned 8.9% in the same...
Flotek Reschedules Third Quarter 2020 Earnings Results
HOUSTON, Nov. 6, 2020 /PRNewswire/ -- Flotek Industries, Inc. ("Flotek" or the "Company") (NYSE: FTK), a technology-driven, specialty chemistry and data company, today announced that it is postponing its third quarter 2020 earnings results previously scheduled for Monday, November 9,...
5 Undervalued Stocks Trading Below the Peter Lynch Value
According to the GuruFocus All-in-One Screener, a Premium feature, as of Oct. 27, the following companies are trading below their Peter Lynch fair value with wide margins of safety and have had positive performances over the past 12 months.
Suicide risk in bipolar patients can be significantly reduced by Electroconvulsive therapy
People suffering from bipolar disorder, or the mental illness where patients exhibit emotional instability, are at a high-risk of suicide but a recent study has revealed that Electroconvulsive Therapy is significantly effective in reducing its chances
Electroconvulsive therapy shown to significantly reduce suicide risk in bipolar patients | Health
One of the largest ever studies of patients with untreatable bipolar disorder has shown that ECT (Electroconvulsive Therapy) was able to reduce suicide risk by 84 per cent in high-risk patients, as well as giving effective treatment to around 72...
Source: https://incomestatements.info
Category: Stock Reports